Correlation Between Nautilus Biotechnology and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nautilus Biotechnology and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nautilus Biotechnology and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nautilus Biotechnology and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Nautilus Biotechnology and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nautilus Biotechnology with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nautilus Biotechnology and Zentalis Pharmaceuticals.
Diversification Opportunities for Nautilus Biotechnology and Zentalis Pharmaceuticals
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nautilus and Zentalis is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Nautilus Biotechnology and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Nautilus Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nautilus Biotechnology are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Nautilus Biotechnology i.e., Nautilus Biotechnology and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nautilus Biotechnology and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Nautilus Biotechnology is expected to generate 0.42 times more return on investment than Zentalis Pharmaceuticals. However, Nautilus Biotechnology is 2.4 times less risky than Zentalis Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.36 per unit of risk. If you would invest 174.00 in Nautilus Biotechnology on November 5, 2024 and sell it today you would lose (3.00) from holding Nautilus Biotechnology or give up 1.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nautilus Biotechnology vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Nautilus Biotechnology |
| Zentalis Pharmaceuticals |
Nautilus Biotechnology and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nautilus Biotechnology and Zentalis Pharmaceuticals
The main advantage of trading using opposite Nautilus Biotechnology and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nautilus Biotechnology position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Nautilus Biotechnology vs. C4 Therapeutics | Nautilus Biotechnology vs. Kymera Therapeutics | Nautilus Biotechnology vs. Foghorn Therapeutics | Nautilus Biotechnology vs. Revolution Medicines |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |